Login / Signup

NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Sara Witting Christensen WenLine NederbyRikke Fredslund AndersenTorben Frøstrup HansenChrista Haugaard NyhusOle HilbergAnders JakobsenTorben Frøstrup Hansen
Published in: British journal of cancer (2023)
Combining NKA and ctDNA status after one cycle of treatment was prognostic in patients with NSCLC treated with PD-1/PD-L1 inhibitors.
Keyphrases
  • nk cells
  • small cell lung cancer
  • circulating tumor
  • advanced non small cell lung cancer
  • long noncoding rna
  • tyrosine kinase
  • epidermal growth factor receptor
  • replacement therapy